Dr Kaasim Mahmood
General Partner at Advent Life Sciences
Kaasim joined Advent in June 2005 having previously spent four years at Cutfield, Freeman & Co, a London based corporate finance boutique where he worked on a wide variety of transactions including financings, mergers and acquisitions. A qualified medical doctor, Kaasim holds an MB BS from the Royal Free & University College Medical School, London.
Advent Life Sciences is one of Europe’s leading venture teams investing in life sciences businesses. The team consists of professionals with extensive scientific, medical and operational experience, and a long-standing track record of entrepreneurial and investment success across the UK, Europe and the US.
The firm invests in a range of sectors within life sciences, principally in new drug discovery, enabling technologies and med tech. Realizations include Algeta, Avila, CardiAQ, CN Creative, EUSA and Micromet. Current investments include Acutus, Arrakis, Aura, Axonics, GMPO and KaNDy.
For more information, please visit www.adventls.com.